Midpregnancy vaginal fluid defensins, bacterial vaginosis, and risk of preterm delivery
about
Antimicrobial peptides in the female reproductive tract: a critical component of the mucosal immune barrier with physiological and clinical implicationsBacterial vaginosis and the cervicovaginal immune response.Evidence for activation of Toll-like receptor and receptor for advanced glycation end products in preterm birth.Treatment of bacterial vaginosis: what we have and what we miss.Use of cervicovaginal fluid for the identification of biomarkers for pathologies of the female genital tract.Midpregnancy levels of angiogenic markers in relation to maternal characteristics.Association of bactericidal activity of genital tract secretions with Escherichia coli colonization in pregnancyDifferential expression pattern of genes encoding for anti-microbial peptides in the fetal membranes of patients with spontaneous preterm labor and intact membranes and those with preterm prelabor rupture of the membranesAssociations between vaginal bacteria and levels of vaginal defensins in pregnant women.Innate immunity in the human female reproductive tract: endocrine regulation of endogenous antimicrobial protection against HIV and other sexually transmitted infections.Bacterial vaginosis and preterm birth.Secreted mucosal antimicrobials in the female reproductive tract that are important to consider for HIV prevention.Bacterial vaginosis: a critical analysis of current knowledge.Efficacy and tolerability of a local acting antiseptic agent in the treatment of vaginal dysbiosis during pregnancy.Maternal serum concentrations of s-Endoglin and IL-6 in pregnancy complicated by preterm premature membrane rupture.European (IUSTI/WHO) guideline on the management of vaginal discharge, 2011
P2860
Q28087327-F4BCD01A-D80F-4CC7-AA6E-3667D07BE1ACQ34027489-6104FFC7-0CA8-4706-A021-24AE33A7CFA2Q34356719-493D53B1-4148-4D64-A329-95916D50C670Q34407439-F3CEFB96-1188-4F08-837C-FB301E7C85A0Q34467932-1E3B03B7-7BE3-4FCD-BBE4-49D0BFB798BEQ34821237-A0E07688-678D-40C6-8F04-1989C313B57DQ36291485-FB3BAAE8-E512-4F91-8DA8-F95BCC8AF422Q36578019-ADCA58D7-A726-4CD8-B398-58701DD87D73Q36758214-A9C2700F-70DF-45C5-9C07-86267A97474EQ37334286-4A74D085-2321-4F0F-8858-BD21D49D9C83Q37953518-584B500C-87C6-4683-87A9-F5D1FEB66808Q38206217-4FFB9608-C422-419C-BCE4-3E8E9BC968C8Q38891336-F8FF41D4-33F8-40E0-AF1F-F175BBEACFC1Q48374640-645FC783-96B3-472A-93FD-EA5535EA5F16Q53428699-C92F6356-D249-431C-9B43-ECD49702FA28Q57703162-4C943EF3-5553-4630-B122-6684925A3AA8
P2860
Midpregnancy vaginal fluid defensins, bacterial vaginosis, and risk of preterm delivery
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Midpregnancy vaginal fluid defensins, bacterial vaginosis, and risk of preterm delivery
@ast
Midpregnancy vaginal fluid defensins, bacterial vaginosis, and risk of preterm delivery
@en
type
label
Midpregnancy vaginal fluid defensins, bacterial vaginosis, and risk of preterm delivery
@ast
Midpregnancy vaginal fluid defensins, bacterial vaginosis, and risk of preterm delivery
@en
prefLabel
Midpregnancy vaginal fluid defensins, bacterial vaginosis, and risk of preterm delivery
@ast
Midpregnancy vaginal fluid defensins, bacterial vaginosis, and risk of preterm delivery
@en
P2093
P2860
P1476
Midpregnancy vaginal fluid defensins, bacterial vaginosis, and risk of preterm delivery
@en
P2093
Alice R Goepfert
Cindy G Arvidson
Claudia B Holzman
Hwan Chung
P2860
P304
P356
10.1097/AOG.0B013E318184209B
P407
P577
2008-09-01T00:00:00Z